Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy

NCT01673204 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

276

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: Calcitriol
DRUG: Placebo

Sponsor

Seoul National University Hospital